Search results

4 items
  1. Policy Responses to Changing Markets of New Psychoactive Substance and Mild Stimulants

    22 December 2014
    Report

    How does national legislation in different EU member states compare and how effective is the adding of new psychoactive substances (NPS) to the existing schedules of drug laws versus legislative experimentation designing new schedules or applying controls under medicines or consumer protection regulations?

  2. cannabis-europe

    Expert Seminar: Costs and benefits of cannabis regulation models in Europe

    30 October 2013

    The Transnational Institute (TNI) organized an expert seminar on Costs and Benefits of Cannabis Regulation Models in Europe in Amsterdam, The Netherlands on October 31/November 1, 2013. The objective of the seminar was to identify and map existing and possible future cannabis regulation models in Europe, looking at the local, provincial and national levels and the po­tential impact of such models on the illicit cannabis market.

  3. Expert Seminar on Herbal Stimulants and Legal Highs

    30 October 2011
    A grey area has emerged between what is legal and what is not as states struggle with how to respond to the many new synthetic compounds emerging onto the market. Of the various types of ‘Legal highs’ the seminar focused on stimulants because of the parallels with the other main drug-policy issue of the moment; i.e. the status of traditional herbal stimulants. These older discussions have been reinvigorated by: Bolivia’s efforts to de-schedule coca-leaf at UN level; the debates on the status of khat between EU States, and of kratom across Asia; and the increasing stride of legitimate cannabis use on the domestic front, as in for example Spain.
  4. Thumbnail

    Expert Seminar on Herbal Stimulants and Legal Highs

    10 October 2011
    Report

    A grey area has emerged between what is legal and what is not as states struggle with how to respond to the many new synthetic compounds emerging onto the market.